ArticleProceedings of the National Academy of Sciences of the United States of America2019

Selective targeting of PARP-2 inhibits androgen receptor signaling and prostate cancer growth through disruption of FOXA1 function.

Bin Gui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.